Stay updated on IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedThe revision history shows a minor update with an addition of Revision: v3.3.2 and deletion of Revision: v3.3.1. These changes are system maintenance details and do not affect study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoChange DetectedRecord History now includes a new revision version (v3.3.1) and shows removal of the previous revision (v3.2.0) in the study's history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the generic operating-status notice regarding funding and update timing. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check33 days agoChange DetectedThe record history shows multiple versions with updates to recruitment status and study status, reflecting ongoing changes to the trial's current state over time.SummaryDifference0.1%

- Check62 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference12%

- Check69 days agoChange DetectedUpdate: version bumped from v3.0.2 to v3.1.0, indicating a new release. No other content changes are indicated.SummaryDifference0.3%

Stay in the know with updates to IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.